CREATIVE MEDICAL TECHNOLOGY (CELZ) Institutional Ownership Changes & 13F Activity
CREATIVE MEDICAL TECHNOLOGY (CELZ). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Myda Advisors Llc, Hudson Bay Capital Management Lp, Anson Funds Management Lp, Acadian Asset Management Llc, and Vanguard Fiduciary Trust Co.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +26,295 | — | 26,295 | $24.57K | Q3 2026 | Nov 16, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -791 | -16.3% | 4,062 | $3.80K | Q3 2026 | Nov 16, 2026 |
| Myda Advisors Llc | Buy | +4,500,000 | — | 4,500,000 | $4.21M | Q3 2026 | Nov 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +56,954 | +1032.1% | 62,472 | $58.41K | Q3 2026 | Nov 13, 2026 |
| Hrt Financial Lp | Buy | +19,918 | — | 19,918 | $18.00 | Q3 2026 | Nov 13, 2026 |
| Morgan Stanley | Sell | -250 | -48.6% | 264 | $247.00 | Q3 2026 | Nov 13, 2026 |
| Ubs Group Ag | Buy | +3,140 | +152.4% | 5,201 | $4.86K | Q3 2026 | Nov 10, 2026 |
| Acadian Asset Management Llc | Buy | +81,293 | — | 81,293 | $74.00 | Q3 2026 | Nov 09, 2026 |
| Geode Capital Management, Llc | Sell | -100 | -0.4% | 25,699 | $24.02K | Q3 2026 | Nov 06, 2026 |
| Stonex Group Inc. | Buy | +15,266 | — | 15,266 | $10.14K | Q3 2026 | Nov 03, 2026 |
| Caitong International Asset Management Co., Ltd | Buy | +1 | — | 1 | $1.00 | Q3 2026 | Oct 29, 2026 |
| Sbi Securities Co., Ltd. | Sell | -42 | -97.7% | 1 | $1.00 | Q3 2026 | Oct 22, 2026 |
| Hudson Bay Capital Management Lp | Sell | -135,170 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Armistice Capital, Llc | Sell | -42,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -26,559 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -54 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Anson Funds Management Lp | Sell | -105,549 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 13, 2026 |
Frequently asked questions about CELZ activity
Which institutional owners are buying CELZ?
Institutional owners buying CELZ include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CELZ activity?
"Buy" means an investor increased their reported position in CELZ compared to the prior reporting period. This reflects growing exposure to CREATIVE MEDICAL TECHNOLOGY (CELZ) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CELZ increasing?
Institutional interest in CELZ can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CELZ Institutional Insights
- CELZ Overview
- CELZ 13F Institutional Holders
- CELZ Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CELZ Insider Trading & SEC Form 4 Activity
- CELZ Articles
- Top Institutional Investor Stock Rankings